TOBINintel · Condition

Depressive & Anxiety Disorders

Mood symptoms are organized, not explained away. Sleep, stress, medications, endocrine factors, nutrient status, metabolic dysfunction, inflammation, substance use, social determinants and exposures are each examined as possible contributors, with validated screening and escalation built in.

Key points

Gut–brain microbial hypotheses are presented as exploratory. No antimicrobial or probiotic protocol is framed as a treatment for a mood disorder.
Test to discuss: Validated depression and anxiety screening with risk assessment
Test to discuss: TSH, CBC, ferritin, B12, folate, vitamin D
Test to discuss: Medication and substance review
Test to discuss: Sleep disorder screening
Sleep regularity
Activity and daylight exposure
Social connection and support planning
Early treatment of thyroid and nutrient deficiencies

Root-cause chain

Chronic sleep restriction → Mood symptom severityA

O · Randomized evidence · Experimental sleep restriction worsens affect; insomnia treatment improves depressive symptoms.

Thyroid dysfunction → Depressive presentationA

B · Established causal · Hypothyroidism can present with depressed mood and reverses with treatment.

Systemic inflammation → Anhedonia and fatigueB

I · Observational association · Cytokine-induced behavior change is well described; causal direction in primary depression is unsettled.

B12, folate or iron deficiency → Fatigue and low moodB

N · Observational association · Deficiency states produce overlapping symptoms and should be corrected before attribution.

Protocols by lane

Evidence grade + regulatory status

Conventional: Evidence-based psychotherapy (CBT, behavioral activation)A

First-line with durable effect across severities.

Status: Lifestyle · Cautions: Escalate immediately for suicidal ideation or psychosis.

Conventional: SSRI or SNRI pharmacotherapyA

Guideline-supported for moderate to severe presentations.

Status: FDA-approved · Cautions: Serotonin syndrome risk with combinations; bleeding risk with anticoagulants; pregnancy discussion required.

Functional: Sleep and circadian correction programA

Insomnia treatment improves depressive outcomes.

Status: Lifestyle · Cautions: Screen for sleep apnea and bipolar history before sleep deprivation strategies.

Orthomolecular: Correction of documented B12, folate, iron or vitamin D deficiencyB

Removes reversible contributors to fatigue and low mood.

Status: Supplement · Cautions: Treat measured deficiency only; not a replacement for mental-health care.

Traditional: St John's wort for mild symptomsB

Trials show benefit in mild depression.

Status: Supplement · Cautions: Major CYP3A4 inducer: interacts with contraceptives, anticoagulants, antiretrovirals, immunosuppressants.

Energy / Physical: Bright-light therapyB

Effective in seasonal patterns and adjunctive in non-seasonal depression.

Status: OTC · Cautions: Mania risk in bipolar disorder; ophthalmologic caution in retinal disease.

Monitoring

Screening score at each visit
Suicide-risk reassessment at every contact when flagged
Medication tolerability review

Go deeper

Full condition page →Library: formulas & sources →All TOBINintel entries

iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.